Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism 11β-HSD1 inhibitors(Corticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H18ClN3O4S2 |
InChIKeyWZFZJEPHYDDFCT-UHFFFAOYSA-N |
CAS Registry376641-49-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 2 | - | - | |
Diabetes Mellitus, Type 2 | Phase 2 | SE | - |